New whitepaper reveals exceptional results in pharmaceutical and life science fluid handling

Fristam has released a groundbreaking whitepaper showcasing the impressive performance of the Fristam FDS twin screw pump in highly sensitive applications across the pharmaceutical and life sciences industries.

Tested by the renowned bioX Applications Lab in Salem, New Hampshire, the FDS pump demonstrated significant advantages in key areas such as mechanical shear, hemolysis, pulsation, and protein stability. These findings underline its suitability for critical fluid handling processes, including cell culture, drug manufacturing, Tangential Flow Filtration (TFF), and chromatography.

Highlights of the whitepaper include:

• Low mechanical shear: The FDS pump preserved particle integrity across variable flow rates and pressures.
• Minimal hemolysis: Less than 5% red blood cell degradation during extended operation.
• Outstanding protein stability: Only a 4% reduction in IgG concentration, outperforming rotary lobe and peristaltic pumps.

These results support the FDS pump as a superior solution for manufacturers who demand precision, reliability, and product integrity in their processes.

But that’s just the beginning, to understand the full scope of the testing, including methodology, detailed results, and application insights, download the complete whitepaper: Download the whitepaper now.

Whether you’re involved in biopharmaceutical production, sterile process systems, or critical hygienic fluid transfer, this whitepaper is essential reading for engineering teams, process designers, and quality managers.

Want to know more about Fristam’s pumps in the pharmaceutical, biopharmaceutical and life sciences industry, look at here.